LONDRES, 11 sept. 2024 (GLOBE NEWSWIRE) — AI–Media, le leader mondial des services de sous–titrage et de traduction optimisés par l’IA, est fier d’annoncer un nouveau partenariat avec ITV, [...] Read more »
AI-Media und ITV kündigen bahnbrechende Partnerschaft zur Revolutionierung von Untertitelungsdiensten an
LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) — AI–Media, der weltweit führende Anbieter von KI–gestützten Untertitelungs– und Übersetzungsdiensten, ist stolz darauf, eine neue Partnerschaft [...] Read more »
AI-Media e ITV Anunciam Parceria Histórica para Revolucionar o Serviço de Legendagem
LONDRES, Sept. 10, 2024 (GLOBE NEWSWIRE) — A AI–Media, líder mundial em soluções de tecnologias completas de legendagem, tem o prazer de anunciar sua nova parceria com a ITV, a maior emissora [...] Read more »
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first–ever look at the critical issue of how some of the largest pharmaceutical companies are reaching [...] Read more »
Neuer Bericht der Access to Medicine Foundation zeigt Einsatz von Pharmaunternehmen für einen besseren Zugang zu Medikamenten für Patienten
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — Der neueste Bericht der Access to Medicine Foundation wirft erstmals einen Blick auf die entscheidende Frage, wie einige der größten Pharmaunternehmen Patienten weltweit [...] Read more »
Un nouveau rapport de l’Access to Medicine Foundation révèle à quel point les efforts des entreprises pharmaceutiques en matière d’accès aux médicaments sont axés sur les patients
AMSTERDAM, 10 sept. 2024 (GLOBE NEWSWIRE) — Le dernier rapport de l’Access to Medicine Foundation se penche pour la première fois sur la question cruciale de l’approche de certaines des plus grandes entreprises [...] Read more »
Um novo relatório da “Access to Medicine Foundation” revela como os esforços de acesso das empresas farmacêuticas estão centrados nos pacientes
AMESTERDÃO, Sept. 10, 2024 (GLOBE NEWSWIRE) — O mais recente relatório da Access to Medicine Foundation analisa, pela primeira vez, a questão crítica de como algumas das maiores empresas farmacêuticas [...] Read more »
“لايفيرا أوميكس” تعيّن خبير الجينوم الكريّع رئيساً للقسم الطبي والجينومي
- لايفيرا أوميكس Read more »
Lifera Omics Appoints Prof. Fowzan Alkuraya, a Renowned Genomics Expert as Chief Medical and Genomic Officer
- Lifera, a biopharma company wholly owned by the Public Investment Fund (PIF), launched in 2023, is scaling up its subsidiary Lifera Omics and developing a team of leading Saudi and global talent to fulfil its [...] Read more »
60 Years After Lyndon Johnson’s “Daisy Ad,” the Silence on Nuclear War Is Dangerous
Sculpture depicting [...] Read more »